nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—CYP3A4—Pilocarpine—glaucoma	0.0851	0.166	CbGbCtD
Tolvaptan—ABCB1—Timolol—glaucoma	0.0816	0.159	CbGbCtD
Tolvaptan—ABCB1—Clonidine—glaucoma	0.0694	0.135	CbGbCtD
Tolvaptan—CYP3A4—Brinzolamide—glaucoma	0.0668	0.13	CbGbCtD
Tolvaptan—CYP3A4—Dorzolamide—glaucoma	0.0645	0.126	CbGbCtD
Tolvaptan—CYP3A4—Methazolamide—glaucoma	0.0575	0.112	CbGbCtD
Tolvaptan—CYP3A4—Acetazolamide—glaucoma	0.046	0.0897	CbGbCtD
Tolvaptan—CYP3A4—Clonidine—glaucoma	0.0416	0.0811	CbGbCtD
Tolvaptan—Vismodegib—SMO—glaucoma	0.0124	1	CrCbGaD
Tolvaptan—ABCB1—ABC-family proteins mediated transport—PEX19—glaucoma	0.00176	0.0381	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—OPN4—glaucoma	0.00153	0.0334	CbGpPWpGaD
Tolvaptan—AVPR1A—G alpha (q) signalling events—PTGFR—glaucoma	0.00138	0.03	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00137	0.0298	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.0013	0.0282	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00129	0.028	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00124	0.0269	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00119	0.0258	CbGpPWpGaD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00118	0.0256	CbGpPWpGaD
Tolvaptan—Immune system disorder—Brinzolamide—glaucoma	0.00109	0.00254	CcSEcCtD
Tolvaptan—Asthenia—Carteolol—glaucoma	0.00109	0.00253	CcSEcCtD
Tolvaptan—Mediastinal disorder—Brinzolamide—glaucoma	0.00109	0.00253	CcSEcCtD
Tolvaptan—Body temperature increased—Methazolamide—glaucoma	0.00109	0.00253	CcSEcCtD
Tolvaptan—Dry mouth—Apraclonidine—glaucoma	0.00108	0.00253	CcSEcCtD
Tolvaptan—Dizziness—Metipranolol—glaucoma	0.00108	0.00252	CcSEcCtD
Tolvaptan—Ill-defined disorder—Acetazolamide—glaucoma	0.00108	0.00252	CcSEcCtD
Tolvaptan—Asthenia—Diclofenamide—glaucoma	0.00107	0.00249	CcSEcCtD
Tolvaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00107	0.0232	CbGpPWpGaD
Tolvaptan—Pollakiuria—Clonidine—glaucoma	0.00107	0.00249	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00107	0.00249	CcSEcCtD
Tolvaptan—AVPR2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00106	0.023	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Levobunolol—glaucoma	0.00106	0.00246	CcSEcCtD
Tolvaptan—Pruritus—Diclofenamide—glaucoma	0.00106	0.00246	CcSEcCtD
Tolvaptan—Breast disorder—Betaxolol—glaucoma	0.00105	0.00245	CcSEcCtD
Tolvaptan—Dry mouth—Bimatoprost—glaucoma	0.00105	0.00245	CcSEcCtD
Tolvaptan—Malaise—Acetazolamide—glaucoma	0.00105	0.00245	CcSEcCtD
Tolvaptan—Malnutrition—Brinzolamide—glaucoma	0.00105	0.00244	CcSEcCtD
Tolvaptan—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.00105	0.00244	CcSEcCtD
Tolvaptan—Dysgeusia—Dorzolamide—glaucoma	0.00105	0.00243	CcSEcCtD
Tolvaptan—Nervous system disorder—Apraclonidine—glaucoma	0.00104	0.00243	CcSEcCtD
Tolvaptan—Dysgeusia—Travoprost—glaucoma	0.00104	0.00242	CcSEcCtD
Tolvaptan—Skin disorder—Apraclonidine—glaucoma	0.00103	0.0024	CcSEcCtD
Tolvaptan—Asthenia—Levobunolol—glaucoma	0.00103	0.0024	CcSEcCtD
Tolvaptan—Dysgeusia—Brinzolamide—glaucoma	0.00103	0.00239	CcSEcCtD
Tolvaptan—Alanine aminotransferase increased—Betaxolol—glaucoma	0.00103	0.00239	CcSEcCtD
Tolvaptan—Headache—Metipranolol—glaucoma	0.00103	0.00239	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00102	0.0221	CbGpPWpGaD
Tolvaptan—Pruritus—Levobunolol—glaucoma	0.00101	0.00236	CcSEcCtD
Tolvaptan—Nervous system disorder—Bimatoprost—glaucoma	0.00101	0.00235	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00101	0.0219	CbGpPWpGaD
Tolvaptan—Dizziness—Carteolol—glaucoma	0.001	0.00234	CcSEcCtD
Tolvaptan—Syncope—Brimonidine—glaucoma	0.001	0.00233	CcSEcCtD
Tolvaptan—Skin disorder—Bimatoprost—glaucoma	0.001	0.00233	CcSEcCtD
Tolvaptan—Diarrhoea—Carbachol—glaucoma	0.000996	0.00232	CcSEcCtD
Tolvaptan—Dysgeusia—Pilocarpine—glaucoma	0.000988	0.0023	CcSEcCtD
Tolvaptan—Ill-defined disorder—Travoprost—glaucoma	0.000986	0.0023	CcSEcCtD
Tolvaptan—Dizziness—Diclofenamide—glaucoma	0.000986	0.0023	CcSEcCtD
Tolvaptan—Asthenia—Methazolamide—glaucoma	0.000985	0.00229	CcSEcCtD
Tolvaptan—Loss of consciousness—Brimonidine—glaucoma	0.000982	0.00229	CcSEcCtD
Tolvaptan—Diarrhoea—Levobunolol—glaucoma	0.000981	0.00228	CcSEcCtD
Tolvaptan—Discomfort—Acetazolamide—glaucoma	0.00098	0.00228	CcSEcCtD
Tolvaptan—Hypoglycaemia—Timolol—glaucoma	0.000975	0.00227	CcSEcCtD
Tolvaptan—Ill-defined disorder—Brinzolamide—glaucoma	0.000974	0.00227	CcSEcCtD
Tolvaptan—Nausea—Metipranolol—glaucoma	0.000973	0.00227	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Timolol—glaucoma	0.000971	0.00226	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—PEX19—glaucoma	0.000963	0.0209	CbGpPWpGaD
Tolvaptan—Dizziness—Carbachol—glaucoma	0.000963	0.00224	CcSEcCtD
Tolvaptan—Malaise—Travoprost—glaucoma	0.000958	0.00223	CcSEcCtD
Tolvaptan—Syncope—Dorzolamide—glaucoma	0.000957	0.00223	CcSEcCtD
Tolvaptan—Anaphylactic shock—Acetazolamide—glaucoma	0.00095	0.00221	CcSEcCtD
Tolvaptan—Headache—Carteolol—glaucoma	0.00095	0.00221	CcSEcCtD
Tolvaptan—Dizziness—Levobunolol—glaucoma	0.000948	0.00221	CcSEcCtD
Tolvaptan—Malaise—Brinzolamide—glaucoma	0.000946	0.0022	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000945	0.0022	CcSEcCtD
Tolvaptan—Pruritus—Latanoprost—glaucoma	0.00094	0.00219	CcSEcCtD
Tolvaptan—Discomfort—Brimonidine—glaucoma	0.00094	0.00219	CcSEcCtD
Tolvaptan—Diarrhoea—Methazolamide—glaucoma	0.00094	0.00219	CcSEcCtD
Tolvaptan—Loss of consciousness—Dorzolamide—glaucoma	0.000938	0.00219	CcSEcCtD
Tolvaptan—Shock—Acetazolamide—glaucoma	0.000935	0.00218	CcSEcCtD
Tolvaptan—Headache—Diclofenamide—glaucoma	0.000934	0.00218	CcSEcCtD
Tolvaptan—Dry mouth—Brimonidine—glaucoma	0.000931	0.00217	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000917	0.00214	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000915	0.0199	CbGpPWpGaD
Tolvaptan—Headache—Carbachol—glaucoma	0.000912	0.00212	CcSEcCtD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000909	0.0197	CbGpPWpGaD
Tolvaptan—Constipation—Apraclonidine—glaucoma	0.000909	0.00212	CcSEcCtD
Tolvaptan—Hyperglycaemia—Betaxolol—glaucoma	0.000908	0.00211	CcSEcCtD
Tolvaptan—Syncope—Pilocarpine—glaucoma	0.000905	0.00211	CcSEcCtD
Tolvaptan—Nausea—Carteolol—glaucoma	0.000901	0.0021	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000899	0.00209	CcSEcCtD
Tolvaptan—Headache—Levobunolol—glaucoma	0.000898	0.00209	CcSEcCtD
Tolvaptan—Discomfort—Dorzolamide—glaucoma	0.000898	0.00209	CcSEcCtD
Tolvaptan—Shock—Brimonidine—glaucoma	0.000898	0.00209	CcSEcCtD
Tolvaptan—Nervous system disorder—Brimonidine—glaucoma	0.000895	0.00208	CcSEcCtD
Tolvaptan—Discomfort—Travoprost—glaucoma	0.000894	0.00208	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000889	0.00207	CcSEcCtD
Tolvaptan—Dry mouth—Dorzolamide—glaucoma	0.000889	0.00207	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000887	0.00207	CcSEcCtD
Tolvaptan—Loss of consciousness—Pilocarpine—glaucoma	0.000887	0.00207	CcSEcCtD
Tolvaptan—Skin disorder—Brimonidine—glaucoma	0.000886	0.00206	CcSEcCtD
Tolvaptan—Nausea—Diclofenamide—glaucoma	0.000886	0.00206	CcSEcCtD
Tolvaptan—Dry mouth—Travoprost—glaucoma	0.000885	0.00206	CcSEcCtD
Tolvaptan—Discomfort—Brinzolamide—glaucoma	0.000883	0.00206	CcSEcCtD
Tolvaptan—Dizziness—Latanoprost—glaucoma	0.000879	0.00205	CcSEcCtD
Tolvaptan—Feeling abnormal—Apraclonidine—glaucoma	0.000876	0.00204	CcSEcCtD
Tolvaptan—Dry mouth—Brinzolamide—glaucoma	0.000874	0.00204	CcSEcCtD
Tolvaptan—Anaphylactic shock—Dorzolamide—glaucoma	0.000871	0.00203	CcSEcCtD
Tolvaptan—Nausea—Carbachol—glaucoma	0.000865	0.00201	CcSEcCtD
Tolvaptan—Headache—Methazolamide—glaucoma	0.00086	0.002	CcSEcCtD
Tolvaptan—Breast disorder—Timolol—glaucoma	0.00086	0.002	CcSEcCtD
Tolvaptan—Cardiac disorder—Clonidine—glaucoma	0.000859	0.002	CcSEcCtD
Tolvaptan—Shock—Dorzolamide—glaucoma	0.000857	0.002	CcSEcCtD
Tolvaptan—Nausea—Levobunolol—glaucoma	0.000851	0.00198	CcSEcCtD
Tolvaptan—Nervous system disorder—Travoprost—glaucoma	0.000851	0.00198	CcSEcCtD
Tolvaptan—Discomfort—Pilocarpine—glaucoma	0.000848	0.00198	CcSEcCtD
Tolvaptan—Skin disorder—Travoprost—glaucoma	0.000843	0.00196	CcSEcCtD
Tolvaptan—Nervous system disorder—Brinzolamide—glaucoma	0.00084	0.00196	CcSEcCtD
Tolvaptan—Angiopathy—Clonidine—glaucoma	0.00084	0.00196	CcSEcCtD
Tolvaptan—Mediastinal disorder—Clonidine—glaucoma	0.000834	0.00194	CcSEcCtD
Tolvaptan—Headache—Latanoprost—glaucoma	0.000833	0.00194	CcSEcCtD
Tolvaptan—Skin disorder—Brinzolamide—glaucoma	0.000832	0.00194	CcSEcCtD
Tolvaptan—Anorexia—Dorzolamide—glaucoma	0.00083	0.00193	CcSEcCtD
Tolvaptan—Decreased appetite—Acetazolamide—glaucoma	0.000826	0.00192	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000821	0.00191	CcSEcCtD
Tolvaptan—Nausea—Methazolamide—glaucoma	0.000816	0.0019	CcSEcCtD
Tolvaptan—Shock—Pilocarpine—glaucoma	0.00081	0.00189	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Brimonidine—glaucoma	0.000788	0.00183	CcSEcCtD
Tolvaptan—Anorexia—Pilocarpine—glaucoma	0.000785	0.00183	CcSEcCtD
Tolvaptan—Feeling abnormal—Acetazolamide—glaucoma	0.000783	0.00182	CcSEcCtD
Tolvaptan—Hypersensitivity—Apraclonidine—glaucoma	0.000783	0.00182	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—OPN4—glaucoma	0.000774	0.0168	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—OPN4—glaucoma	0.000769	0.0167	CbGpPWpGaD
Tolvaptan—Asthenia—Apraclonidine—glaucoma	0.000762	0.00178	CcSEcCtD
Tolvaptan—Decreased appetite—Dorzolamide—glaucoma	0.000757	0.00176	CcSEcCtD
Tolvaptan—Pruritus—Apraclonidine—glaucoma	0.000752	0.00175	CcSEcCtD
Tolvaptan—Body temperature increased—Acetazolamide—glaucoma	0.000751	0.00175	CcSEcCtD
Tolvaptan—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00075	0.0163	CbGpPWpGaD
Tolvaptan—Gastrointestinal disorder—Travoprost—glaucoma	0.000749	0.00174	CcSEcCtD
Tolvaptan—Cardiac disorder—Betaxolol—glaucoma	0.000748	0.00174	CcSEcCtD
Tolvaptan—Ill-defined disorder—Clonidine—glaucoma	0.000747	0.00174	CcSEcCtD
Tolvaptan—Decreased appetite—Brinzolamide—glaucoma	0.000745	0.00173	CcSEcCtD
Tolvaptan—Constipation—Travoprost—glaucoma	0.000742	0.00173	CcSEcCtD
Tolvaptan—Hyperglycaemia—Timolol—glaucoma	0.000742	0.00173	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000739	0.00172	CcSEcCtD
Tolvaptan—Asthenia—Bimatoprost—glaucoma	0.000739	0.00172	CcSEcCtD
Tolvaptan—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000733	0.0159	CbGpPWpGaD
Tolvaptan—Angiopathy—Betaxolol—glaucoma	0.000731	0.0017	CcSEcCtD
Tolvaptan—Pruritus—Bimatoprost—glaucoma	0.000729	0.0017	CcSEcCtD
Tolvaptan—Immune system disorder—Betaxolol—glaucoma	0.000728	0.00169	CcSEcCtD
Tolvaptan—Diarrhoea—Apraclonidine—glaucoma	0.000727	0.00169	CcSEcCtD
Tolvaptan—Malaise—Clonidine—glaucoma	0.000726	0.00169	CcSEcCtD
Tolvaptan—Mediastinal disorder—Betaxolol—glaucoma	0.000726	0.00169	CcSEcCtD
Tolvaptan—Syncope—Clonidine—glaucoma	0.000722	0.00168	CcSEcCtD
Tolvaptan—Feeling abnormal—Dorzolamide—glaucoma	0.000718	0.00167	CcSEcCtD
Tolvaptan—Decreased appetite—Pilocarpine—glaucoma	0.000716	0.00167	CcSEcCtD
Tolvaptan—Feeling abnormal—Travoprost—glaucoma	0.000715	0.00167	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000711	0.00166	CcSEcCtD
Tolvaptan—Loss of consciousness—Clonidine—glaucoma	0.000708	0.00165	CcSEcCtD
Tolvaptan—Feeling abnormal—Brinzolamide—glaucoma	0.000706	0.00164	CcSEcCtD
Tolvaptan—Constipation—Pilocarpine—glaucoma	0.000704	0.00164	CcSEcCtD
Tolvaptan—Dizziness—Apraclonidine—glaucoma	0.000703	0.00164	CcSEcCtD
Tolvaptan—Malnutrition—Betaxolol—glaucoma	0.000701	0.00163	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—PTGFR—glaucoma	0.000697	0.0151	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—PTGFR—glaucoma	0.000692	0.015	CbGpPWpGaD
Tolvaptan—Body temperature increased—Dorzolamide—glaucoma	0.000689	0.0016	CcSEcCtD
Tolvaptan—Dysgeusia—Betaxolol—glaucoma	0.000687	0.0016	CcSEcCtD
Tolvaptan—Asthenia—Acetazolamide—glaucoma	0.000682	0.00159	CcSEcCtD
Tolvaptan—Dizziness—Bimatoprost—glaucoma	0.000681	0.00159	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000681	0.00159	CcSEcCtD
Tolvaptan—Feeling abnormal—Pilocarpine—glaucoma	0.000678	0.00158	CcSEcCtD
Tolvaptan—Discomfort—Clonidine—glaucoma	0.000678	0.00158	CcSEcCtD
Tolvaptan—Hypersensitivity—Brimonidine—glaucoma	0.000672	0.00157	CcSEcCtD
Tolvaptan—Dry mouth—Clonidine—glaucoma	0.000671	0.00156	CcSEcCtD
Tolvaptan—Headache—Apraclonidine—glaucoma	0.000666	0.00155	CcSEcCtD
Tolvaptan—Asthenia—Brimonidine—glaucoma	0.000655	0.00152	CcSEcCtD
Tolvaptan—Body temperature increased—Pilocarpine—glaucoma	0.000651	0.00152	CcSEcCtD
Tolvaptan—Ill-defined disorder—Betaxolol—glaucoma	0.000651	0.00152	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00065	0.0141	CbGpPWpGaD
Tolvaptan—Diarrhoea—Acetazolamide—glaucoma	0.00065	0.00151	CcSEcCtD
Tolvaptan—Shock—Clonidine—glaucoma	0.000647	0.00151	CcSEcCtD
Tolvaptan—Connective tissue disorder—Timolol—glaucoma	0.000647	0.00151	CcSEcCtD
Tolvaptan—Pruritus—Brimonidine—glaucoma	0.000645	0.0015	CcSEcCtD
Tolvaptan—Headache—Bimatoprost—glaucoma	0.000645	0.0015	CcSEcCtD
Tolvaptan—Nervous system disorder—Clonidine—glaucoma	0.000645	0.0015	CcSEcCtD
Tolvaptan—Hypersensitivity—Dorzolamide—glaucoma	0.000642	0.0015	CcSEcCtD
Tolvaptan—Hypersensitivity—Travoprost—glaucoma	0.000639	0.00149	CcSEcCtD
Tolvaptan—Skin disorder—Clonidine—glaucoma	0.000639	0.00149	CcSEcCtD
Tolvaptan—Malaise—Betaxolol—glaucoma	0.000632	0.00147	CcSEcCtD
Tolvaptan—Nausea—Apraclonidine—glaucoma	0.000631	0.00147	CcSEcCtD
Tolvaptan—Hypersensitivity—Brinzolamide—glaucoma	0.000631	0.00147	CcSEcCtD
Tolvaptan—Syncope—Betaxolol—glaucoma	0.000629	0.00146	CcSEcCtD
Tolvaptan—Dizziness—Acetazolamide—glaucoma	0.000629	0.00146	CcSEcCtD
Tolvaptan—Anorexia—Clonidine—glaucoma	0.000627	0.00146	CcSEcCtD
Tolvaptan—Asthenia—Dorzolamide—glaucoma	0.000625	0.00146	CcSEcCtD
Tolvaptan—Asthenia—Travoprost—glaucoma	0.000622	0.00145	CcSEcCtD
Tolvaptan—Pruritus—Dorzolamide—glaucoma	0.000616	0.00144	CcSEcCtD
Tolvaptan—Loss of consciousness—Betaxolol—glaucoma	0.000616	0.00144	CcSEcCtD
Tolvaptan—Asthenia—Brinzolamide—glaucoma	0.000615	0.00143	CcSEcCtD
Tolvaptan—Pruritus—Travoprost—glaucoma	0.000614	0.00143	CcSEcCtD
Tolvaptan—Nausea—Bimatoprost—glaucoma	0.000612	0.00143	CcSEcCtD
Tolvaptan—Cardiac disorder—Timolol—glaucoma	0.000611	0.00142	CcSEcCtD
Tolvaptan—Hypersensitivity—Pilocarpine—glaucoma	0.000607	0.00141	CcSEcCtD
Tolvaptan—Pruritus—Brinzolamide—glaucoma	0.000606	0.00141	CcSEcCtD
Tolvaptan—Dizziness—Brimonidine—glaucoma	0.000603	0.00141	CcSEcCtD
Tolvaptan—Angiopathy—Timolol—glaucoma	0.000597	0.00139	CcSEcCtD
Tolvaptan—Diarrhoea—Dorzolamide—glaucoma	0.000596	0.00139	CcSEcCtD
Tolvaptan—Headache—Acetazolamide—glaucoma	0.000595	0.00139	CcSEcCtD
Tolvaptan—Immune system disorder—Timolol—glaucoma	0.000594	0.00138	CcSEcCtD
Tolvaptan—Diarrhoea—Travoprost—glaucoma	0.000594	0.00138	CcSEcCtD
Tolvaptan—Mediastinal disorder—Timolol—glaucoma	0.000593	0.00138	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000593	0.00138	CcSEcCtD
Tolvaptan—Asthenia—Pilocarpine—glaucoma	0.000591	0.00138	CcSEcCtD
Tolvaptan—Discomfort—Betaxolol—glaucoma	0.00059	0.00137	CcSEcCtD
Tolvaptan—Diarrhoea—Brinzolamide—glaucoma	0.000586	0.00137	CcSEcCtD
Tolvaptan—Dry mouth—Betaxolol—glaucoma	0.000584	0.00136	CcSEcCtD
Tolvaptan—Pruritus—Pilocarpine—glaucoma	0.000582	0.00136	CcSEcCtD
Tolvaptan—Dizziness—Dorzolamide—glaucoma	0.000576	0.00134	CcSEcCtD
Tolvaptan—Dizziness—Travoprost—glaucoma	0.000574	0.00134	CcSEcCtD
Tolvaptan—Malnutrition—Timolol—glaucoma	0.000573	0.00133	CcSEcCtD
Tolvaptan—Headache—Brimonidine—glaucoma	0.000571	0.00133	CcSEcCtD
Tolvaptan—Decreased appetite—Clonidine—glaucoma	0.000571	0.00133	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Clonidine—glaucoma	0.000568	0.00132	CcSEcCtD
Tolvaptan—Dizziness—Brinzolamide—glaucoma	0.000566	0.00132	CcSEcCtD
Tolvaptan—Nausea—Acetazolamide—glaucoma	0.000565	0.00132	CcSEcCtD
Tolvaptan—Diarrhoea—Pilocarpine—glaucoma	0.000563	0.00131	CcSEcCtD
Tolvaptan—Shock—Betaxolol—glaucoma	0.000563	0.00131	CcSEcCtD
Tolvaptan—Constipation—Clonidine—glaucoma	0.000562	0.00131	CcSEcCtD
Tolvaptan—Nervous system disorder—Betaxolol—glaucoma	0.000561	0.00131	CcSEcCtD
Tolvaptan—Dysgeusia—Timolol—glaucoma	0.000561	0.00131	CcSEcCtD
Tolvaptan—Skin disorder—Betaxolol—glaucoma	0.000556	0.00129	CcSEcCtD
Tolvaptan—Headache—Dorzolamide—glaucoma	0.000546	0.00127	CcSEcCtD
Tolvaptan—Anorexia—Betaxolol—glaucoma	0.000546	0.00127	CcSEcCtD
Tolvaptan—Dizziness—Pilocarpine—glaucoma	0.000544	0.00127	CcSEcCtD
Tolvaptan—Headache—Travoprost—glaucoma	0.000543	0.00127	CcSEcCtD
Tolvaptan—Nausea—Brimonidine—glaucoma	0.000542	0.00126	CcSEcCtD
Tolvaptan—Feeling abnormal—Clonidine—glaucoma	0.000542	0.00126	CcSEcCtD
Tolvaptan—Headache—Brinzolamide—glaucoma	0.000537	0.00125	CcSEcCtD
Tolvaptan—Body temperature increased—Clonidine—glaucoma	0.00052	0.00121	CcSEcCtD
Tolvaptan—Nausea—Dorzolamide—glaucoma	0.000517	0.00121	CcSEcCtD
Tolvaptan—Headache—Pilocarpine—glaucoma	0.000516	0.0012	CcSEcCtD
Tolvaptan—Nausea—Travoprost—glaucoma	0.000515	0.0012	CcSEcCtD
Tolvaptan—Syncope—Timolol—glaucoma	0.000514	0.0012	CcSEcCtD
Tolvaptan—Nausea—Brinzolamide—glaucoma	0.000509	0.00119	CcSEcCtD
Tolvaptan—Loss of consciousness—Timolol—glaucoma	0.000504	0.00117	CcSEcCtD
Tolvaptan—Decreased appetite—Betaxolol—glaucoma	0.000498	0.00116	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Betaxolol—glaucoma	0.000494	0.00115	CcSEcCtD
Tolvaptan—Constipation—Betaxolol—glaucoma	0.000489	0.00114	CcSEcCtD
Tolvaptan—Nausea—Pilocarpine—glaucoma	0.000489	0.00114	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000484	0.00113	CcSEcCtD
Tolvaptan—Hypersensitivity—Clonidine—glaucoma	0.000484	0.00113	CcSEcCtD
Tolvaptan—Discomfort—Timolol—glaucoma	0.000482	0.00112	CcSEcCtD
Tolvaptan—Dry mouth—Timolol—glaucoma	0.000477	0.00111	CcSEcCtD
Tolvaptan—Asthenia—Clonidine—glaucoma	0.000472	0.0011	CcSEcCtD
Tolvaptan—Feeling abnormal—Betaxolol—glaucoma	0.000472	0.0011	CcSEcCtD
Tolvaptan—Anaphylactic shock—Timolol—glaucoma	0.000468	0.00109	CcSEcCtD
Tolvaptan—Pruritus—Clonidine—glaucoma	0.000465	0.00108	CcSEcCtD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000462	0.01	CbGpPWpGaD
Tolvaptan—Shock—Timolol—glaucoma	0.00046	0.00107	CcSEcCtD
Tolvaptan—AVPR1A—G alpha (q) signalling events—EDN1—glaucoma	0.000459	0.00998	CbGpPWpGaD
Tolvaptan—Nervous system disorder—Timolol—glaucoma	0.000459	0.00107	CcSEcCtD
Tolvaptan—Skin disorder—Timolol—glaucoma	0.000454	0.00106	CcSEcCtD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—EDN1—glaucoma	0.000454	0.00986	CbGpPWpGaD
Tolvaptan—Body temperature increased—Betaxolol—glaucoma	0.000452	0.00105	CcSEcCtD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—EDN1—glaucoma	0.00045	0.00979	CbGpPWpGaD
Tolvaptan—Diarrhoea—Clonidine—glaucoma	0.00045	0.00105	CcSEcCtD
Tolvaptan—Anorexia—Timolol—glaucoma	0.000446	0.00104	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—OPN4—glaucoma	0.000437	0.00951	CbGpPWpGaD
Tolvaptan—Dizziness—Clonidine—glaucoma	0.000435	0.00101	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—OPN4—glaucoma	0.000434	0.00944	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000434	0.00943	CbGpPWpGaD
Tolvaptan—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000431	0.00936	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Betaxolol—glaucoma	0.000422	0.000982	CcSEcCtD
Tolvaptan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.00042	0.00913	CbGpPWpGaD
Tolvaptan—Headache—Clonidine—glaucoma	0.000412	0.000959	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000411	0.00893	CbGpPWpGaD
Tolvaptan—Asthenia—Betaxolol—glaucoma	0.000411	0.000957	CcSEcCtD
Tolvaptan—Decreased appetite—Timolol—glaucoma	0.000406	0.000947	CcSEcCtD
Tolvaptan—Pruritus—Betaxolol—glaucoma	0.000405	0.000943	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Timolol—glaucoma	0.000404	0.00094	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—OPN4—glaucoma	0.000397	0.00863	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—C3—glaucoma	0.000396	0.00861	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—OPN4—glaucoma	0.000394	0.00857	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—PTGFR—glaucoma	0.000394	0.00856	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—C3—glaucoma	0.000393	0.00855	CbGpPWpGaD
Tolvaptan—Diarrhoea—Betaxolol—glaucoma	0.000392	0.000912	CcSEcCtD
Tolvaptan—AVPR2—GPCR downstream signaling—PTGFR—glaucoma	0.000391	0.0085	CbGpPWpGaD
Tolvaptan—Nausea—Clonidine—glaucoma	0.00039	0.00091	CcSEcCtD
Tolvaptan—Feeling abnormal—Timolol—glaucoma	0.000385	0.000897	CcSEcCtD
Tolvaptan—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000381	0.00827	CbGpPWpGaD
Tolvaptan—Dizziness—Betaxolol—glaucoma	0.000378	0.000882	CcSEcCtD
Tolvaptan—Body temperature increased—Timolol—glaucoma	0.00037	0.000861	CcSEcCtD
Tolvaptan—Headache—Betaxolol—glaucoma	0.000359	0.000835	CcSEcCtD
Tolvaptan—AVPR1A—Signaling by GPCR—PTGFR—glaucoma	0.000358	0.00777	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PTGFR—glaucoma	0.000355	0.00772	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—SMO—glaucoma	0.000351	0.00764	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—SMO—glaucoma	0.000349	0.00758	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Timolol—glaucoma	0.000344	0.000802	CcSEcCtD
Tolvaptan—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000344	0.00748	CbGpPWpGaD
Tolvaptan—Nausea—Betaxolol—glaucoma	0.00034	0.000792	CcSEcCtD
Tolvaptan—AVPR1A—Signaling Pathways—LRP12—glaucoma	0.000339	0.00736	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LRP12—glaucoma	0.000336	0.0073	CbGpPWpGaD
Tolvaptan—Asthenia—Timolol—glaucoma	0.000335	0.000781	CcSEcCtD
Tolvaptan—Pruritus—Timolol—glaucoma	0.000331	0.000771	CcSEcCtD
Tolvaptan—Diarrhoea—Timolol—glaucoma	0.00032	0.000745	CcSEcCtD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000318	0.0069	CbGpPWpGaD
Tolvaptan—Dizziness—Timolol—glaucoma	0.000309	0.00072	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000304	0.00661	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000302	0.00656	CbGpPWpGaD
Tolvaptan—Headache—Timolol—glaucoma	0.000293	0.000682	CcSEcCtD
Tolvaptan—Nausea—Timolol—glaucoma	0.000278	0.000647	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000266	0.00578	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000264	0.00573	CbGpPWpGaD
Tolvaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000259	0.00563	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—OPN4—glaucoma	0.000235	0.0051	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—OPN4—glaucoma	0.000233	0.00506	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—EDN1—glaucoma	0.000232	0.00503	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—EDN1—glaucoma	0.00023	0.005	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HEYL—glaucoma	0.000218	0.00474	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HEYL—glaucoma	0.000217	0.00471	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PTGFR—glaucoma	0.000211	0.00459	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PTGFR—glaucoma	0.00021	0.00456	CbGpPWpGaD
Tolvaptan—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000203	0.00442	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—C3—glaucoma	0.000202	0.0044	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—C3—glaucoma	0.000201	0.00437	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.0002	0.00434	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000183	0.00399	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—SMO—glaucoma	0.00018	0.00392	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—SMO—glaucoma	0.000179	0.00389	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000172	0.00374	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RPTOR—glaucoma	0.000165	0.00359	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000164	0.00357	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RPTOR—glaucoma	0.000164	0.00357	CbGpPWpGaD
Tolvaptan—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000162	0.00352	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NCK2—glaucoma	0.00016	0.00348	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NCK2—glaucoma	0.000159	0.00345	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—FAS—glaucoma	0.000153	0.00333	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—C3—glaucoma	0.000151	0.00329	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HDAC9—glaucoma	0.000136	0.00296	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HDAC9—glaucoma	0.000135	0.00294	CbGpPWpGaD
Tolvaptan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000134	0.00291	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000133	0.0029	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—EDN1—glaucoma	0.000131	0.00285	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—EDN1—glaucoma	0.00013	0.00282	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00013	0.00282	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000124	0.00269	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EDN1—glaucoma	0.000119	0.00258	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EDN1—glaucoma	0.000118	0.00257	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—C3—glaucoma	0.000114	0.00249	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—C3—glaucoma	0.000114	0.00247	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SMO—glaucoma	0.000107	0.00232	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SMO—glaucoma	0.000106	0.0023	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—C3—glaucoma	0.000104	0.00226	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—C3—glaucoma	0.000103	0.00224	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NARFL—glaucoma	0.000101	0.0022	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CA5A—glaucoma	0.000101	0.0022	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NTRK2—glaucoma	9.74e-05	0.00212	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NTRK2—glaucoma	9.67e-05	0.0021	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	9.66e-05	0.0021	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	8.9e-05	0.00193	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTT1—glaucoma	8.88e-05	0.00193	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	8.85e-05	0.00192	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	8.77e-05	0.00191	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NGFR—glaucoma	8.36e-05	0.00182	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NGFR—glaucoma	8.3e-05	0.0018	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	8.27e-05	0.0018	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NTRK1—glaucoma	7.94e-05	0.00173	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NTRK1—glaucoma	7.89e-05	0.00171	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—glaucoma	7.6e-05	0.00165	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	7.57e-05	0.00164	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN2B—glaucoma	7.32e-05	0.00159	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN2B—glaucoma	7.27e-05	0.00158	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP1B1—glaucoma	7.08e-05	0.00154	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EDN1—glaucoma	7.02e-05	0.00153	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.98e-05	0.00152	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EDN1—glaucoma	6.97e-05	0.00152	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—glaucoma	6.51e-05	0.00142	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	6.47e-05	0.00141	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NGF—glaucoma	6.46e-05	0.0014	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NGF—glaucoma	6.41e-05	0.00139	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NARFL—glaucoma	6.23e-05	0.00135	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA5A—glaucoma	6.23e-05	0.00135	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—C3—glaucoma	6.14e-05	0.00133	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—C3—glaucoma	6.09e-05	0.00132	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.05e-05	0.00131	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOE—glaucoma	5.71e-05	0.00124	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOE—glaucoma	5.67e-05	0.00123	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CAV1—glaucoma	5.66e-05	0.00123	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.66e-05	0.00123	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CAV1—glaucoma	5.62e-05	0.00122	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	5.58e-05	0.00121	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FN1—glaucoma	5.39e-05	0.00117	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FN1—glaucoma	5.35e-05	0.00116	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—BAD—glaucoma	5.32e-05	0.00116	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BAD—glaucoma	5.29e-05	0.00115	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CA1—glaucoma	4.93e-05	0.00107	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CTSA—glaucoma	4.78e-05	0.00104	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	4.76e-05	0.00103	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CA2—glaucoma	4.51e-05	0.000981	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	4.51e-05	0.00098	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—glaucoma	4.28e-05	0.00093	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—glaucoma	4.25e-05	0.000923	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	3.75e-05	0.000815	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDKN1B—glaucoma	3.71e-05	0.000806	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDKN1B—glaucoma	3.68e-05	0.0008	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—glaucoma	3.43e-05	0.000746	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—glaucoma	3.41e-05	0.000741	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	3.21e-05	0.000698	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TXN—glaucoma	3.18e-05	0.000691	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—glaucoma	3.08e-05	0.00067	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—glaucoma	3.06e-05	0.000665	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA1—glaucoma	3.04e-05	0.000661	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CTSA—glaucoma	2.94e-05	0.00064	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	2.83e-05	0.000616	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA2—glaucoma	2.78e-05	0.000604	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTT1—glaucoma	2.47e-05	0.000536	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TP53—glaucoma	2.33e-05	0.000506	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TP53—glaucoma	2.31e-05	0.000503	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1B1—glaucoma	1.96e-05	0.000427	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCA1—glaucoma	1.96e-05	0.000427	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TXN—glaucoma	1.96e-05	0.000426	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—glaucoma	1.57e-05	0.000341	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTT1—glaucoma	1.52e-05	0.00033	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—glaucoma	1.39e-05	0.000302	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOE—glaucoma	1.29e-05	0.000281	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAV1—glaucoma	1.28e-05	0.000278	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1B1—glaucoma	1.21e-05	0.000263	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCA1—glaucoma	1.21e-05	0.000263	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—glaucoma	9.68e-06	0.00021	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—glaucoma	9.68e-06	0.00021	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—glaucoma	8.85e-06	0.000192	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—glaucoma	8.55e-06	0.000186	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOE—glaucoma	7.96e-06	0.000173	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAV1—glaucoma	7.89e-06	0.000171	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—glaucoma	5.96e-06	0.00013	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—glaucoma	5.45e-06	0.000119	CbGpPWpGaD
